| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0090-4295(77)90101-7 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0090429577901017?httpAccept=text/xml |
| https://api.elsevier.com/content/article/PII:0090429577901017?httpAccept=text/plain | ||
| P698 | PubMed publication ID | 414402 |
| P2093 | author name string | D. Byar | |
| C. Blackard | |||
| P2860 | cites work | Chemotherapy for bladder cancer | Q33462155 |
| Evaluation of survival data and two new rank order statistics arising in its consideration | Q34054360 | ||
| Anergy and Tryptophan Metabolism in Bladder Cancer | Q43853948 | ||
| Abnormal tryptophan metabolism in a family with a history of bladder cancer | Q44663229 | ||
| Mitomycin C Bladder Instillation Therapy for Bladder Tumors | Q45039683 | ||
| EORTC randomized trial for the adjuvant therapy of T1 bladder carcinoma | Q67534900 | ||
| Benign Papilloma or Papillary Carcinoma of the Bladder? | Q69557964 | ||
| Relationship between tryptophan metabolism and heterotopic recurrences of human urinary bladder tumors | Q71502495 | ||
| Current clinical problems regarding bladder tumors | Q74079947 | ||
| THE METABOLISM OF TRYPTOPHAN IN PATIENTS WITH BLADDER CANCER AND OTHER UROLOGICAL DISEASES | Q76641104 | ||
| MOUSE BLADDER CARCINOGENICITY OF CERTAIN TRYPTOPHAN METABOLITES AND OTHER AROMATIC NITROGEN COMPOUNDS SUSPENDED IN CHOLESTEROL | Q76901345 | ||
| Maximum utilization of the life table method in analyzing survival | Q78427677 | ||
| Thiotepa in the treatment of tumours of the bladder | Q79125292 | ||
| The metabolism of tryptophan in patients with bladder cancer | Q79175690 | ||
| Bladder carcinoma treated by direct instillation of thio-TEPA | Q79434605 | ||
| Studies on the etiology of carcinoma of the urinary bladder | Q79656421 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | urology | Q105650 |
| placebo | Q269829 | ||
| pyridoxine | Q423746 | ||
| P304 | page(s) | 556-561 | |
| P577 | publication date | 1977-12-01 | |
| P1433 | published in | Urology | Q7900884 |
| P1476 | title | Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer | |
| P478 | volume | 10 |
| Q35679939 | A Simple Class of Bayesian Nonparametric Autoregression Models |
| Q32135687 | A semiparametric model for the analysis of recurrent-event panel data |
| Q39673974 | Adjuvant Therapy of T1 Bladder Carcinoma: Preliminary Results of an EORTC Randomized Study |
| Q33851141 | An overview of the treatment of superficial bladder cancer. Intravesical chemotherapy |
| Q57723936 | Bayesian first order auto-regressive latent variable models for multiple binary sequences |
| Q37279019 | Bladder cancer: chemoprevention, complementary approaches and budgetary considerations |
| Q49479448 | Body Mass Index, Diet-Related Factors, and Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis |
| Q37472582 | Chemoprevention in bladder cancer: What's new? |
| Q34729790 | Chemoprevention of bladder cancer |
| Q79263915 | Chemoprevention of bladder cancer |
| Q77070095 | Chemoprevention of superficial bladder cancer |
| Q53341849 | Chemopreventive trials in urologic cancer. |
| Q70454962 | Cooperative studies of chemoprophylaxis after transurethral resection of bladder tumors |
| Q33686830 | Current Therapy of Bladder Carcinoma |
| Q34205117 | Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium |
| Q37677736 | Effects of Vitamin and Antioxidant Supplements in Prevention of Bladder Cancer: a Meta-Analysis of Randomized Controlled Trials |
| Q38075423 | Effects of vitamin B6 metabolism on oncogenesis, tumor progression and therapeutic responses |
| Q41253985 | Efficient scheduling of cystoscopies in monitoring for recurrent bladder cancer |
| Q37283563 | Emerging intravesical therapies for management of nonmuscle invasive bladder cancer |
| Q37198053 | In vitro regulation of cell growth and angiogenesis by inositol hexaphosphate in bladder cancer |
| Q40108448 | Intravesical chemotherapy in the United States. An overview. |
| Q73755473 | Intravesical therapy of superficial bladder cancer |
| Q88497233 | Lifestyle and nutritional modifiable factors in the prevention and treatment of bladder cancer |
| Q34498662 | Management of bladder cancer |
| Q48680609 | Modeling tumor onset and multiplicity using transition models with latent variables |
| Q31031871 | Multiple outputation for the analysis of longitudinal data subject to irregular observation |
| Q35219328 | Pathobiology and chemoprevention of bladder cancer |
| Q36687595 | Poisson regression analysis in clinical research |
| Q74440986 | Potential lifestyle and dietary supplement options for the prevention and postdiagnosis of bladder cancer |
| Q35684330 | Prognostic variables and surgical management of foot melanoma: review of a 25-year institutional experience |
| Q70362724 | Prophylaxis of superficial bladder cancer with instillation of adriamycin or mitomycin C |
| Q70454969 | Randomized clinical trial on chemoprophylaxis of recurrence in cases of superficial bladder cancer |
| Q45845102 | Recurrence of superficial bladder tumours after transurethral resection |
| Q30234740 | Sulforaphane for the chemoprevention of bladder cancer: molecular mechanism targeted approach |
| Q74654761 | Superficial bladder cancer |
| Q70335929 | Systemic therapy for superficial bladder cancer |
| Q88230171 | The Management of Superficial Bladder Cancer |
| Q30906262 | The gamma-frailty Poisson model for the nonparametric estimation of panel count data |
| Q37871939 | The role of vitamins in cancer: a review |
| Q37198049 | Thiotepa versus Bacille Calmette-Guérin in Non-Muscle Invasive Bladder Cancer |
| Q35645524 | Treatment of superficial bladder cancer |
| Q31111817 | Wei, Lin and Weissfeld's marginal analysis of multivariate failure time data: should it be applied to a recurrent events outcome? |
Search more.